Email updates

Keep up to date with the latest news and content from BMC Medical Physics and BioMed Central.

Open Access Research article

Sodium pertechnetate (Na99mTcO4) biodistribution in mice exposed to cigarette smoke

Samuel S Valenca1*, Elaine AC Lima2, Gláucio F Dire2, Mário Bernardo-Filho2 and Luís Cristóvão Porto1

Author affiliations

1 Departamento de Histologia e Embriologia, Universidade do Estado do Rio de Janeiro, Av. Prof. Manoel de Abreu 444 3° andar – Rio de Janeiro, RJ – 20551-170 Brasil

2 Departamento de Biofísica e Biometria, Universidade do Estado do Rio de Janeiro, Av. Prof. Manoel de Abreu 444 3° andar – Rio de Janeiro, RJ – 20551-170 Brasil

For all author emails, please log on.

Citation and License

BMC Nuclear Medicine 2005, 5:1  doi:10.1186/1471-2385-5-1

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2385/5/1


Received:26 July 2004
Accepted:11 April 2005
Published:11 April 2005

© 2005 Valenca et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The biological effects of cigarette smoke are not fully known. To improve our understanding of the action of various chemical agents, we investigated the biodistribution of sodium pertechnetate (Na99mTcO4) in mice exposed to cigarette smoke.

Methods

Fifteen BALB/c male mice were exposed to the smoke of nine whole commercial cigarettes per day, 3 times/day, for up to 10 days to whole body exposure in a chamber. A control group of 5 BALB/c male mice was sham-smoked. One day later, the exposed and control groups of mice received (7.4 MBq/0.3 ml) of Na99mTcO4 before being killed at 30 min. Bones, brain, heart, intestine, kidney, liver, lungs, muscle, pancreas, spleen, stomach, testis and thyroid were weighed and these organs and blood radioactivity recorded with a gamma counter. The percentage per gram of tissue of injected dose (%ID/g) was determined for each organ.

Results

Cigarette smoke significantly decreased (p < 0.05) the %ID/g in red blood cells, bone, kidney, lung, spleen, stomach, testis and thyroid of the exposed mice.

Conclusion

The toxic effects of cigarette smoke reduced the Na99mTcO4 biodistribution.

Background

Tobacco can be smoked in cigarettes, cigars, pipe, water pipes, or chewed. It is as an important cash crop, and has vast economical impact affecting the livelihoods of the farmers growing it, the companies that manufacture it, and the healthcare system that deals with the consequences of using it. Cigarette smoking (CS), the most popular method of smoking tobacco, is one of the most prevalent social habits practiced worldwide today [1]. The World Health Organization estimated that almost 1.1 billion people are smokers. Smoking has been identified as the leading preventable cause of death and disability in the world [2,3].

The development of diagnostic tools using radioisotopes is widely used in almost all hospitals nationwide. In nuclear medicine practice, physicians set norms for morphological or physiological function for each organ by diagnosing a large number of patients. For every procedure, there is diagnostic data for a range of normal variations familiar to physicians. Nuclear medicine practitioners interpret diseases on the basis of deviations from these limits [4]. Radioisotopes provide vital information to help diagnosis and therapy of various medical diseases. Data on tissue shape, function and localization within the body are relayed by use of one of various radionuclides, which can either be a free chemical species or covalently bound to part of a larger organic or inorganic moiety. These images are generated by the distribution of radioactive decay of the nuclide [5]. Technetium-99m (99mTc) is the most frequently used radionuclide in diagnostic nuclear medicine procedures for a wide variety of diseases [6]. Various radiochemicals have been labelled with this nuclide. 99mTc has a half-life of 6 h and emits γ-rays of 140 keV with an abundance of 90%. 99mTc is primarily obtained from 99Mo/99mTc generator and is eluted as sodium pertechnetate (Na99mTcO4). In this chemical form, it can be used to study brain and thyroid [7]. Intravenously administered 99mTc-pertechnetate is loosely bound to plasma proteins and rapidly moves out of the intravenous compartment. The plasma half-time clearance is ~30 min. Approximately 30% of the administered dose is excreted within 24 h. The total urinary and faecal excretion of 99mTc activity is about 50% in 3 days and up to 70% after 8 days. 99mTc is also trapped by the thyroid gland and it passes into the small intestine. However in the brain, the blood-brain barrier prevents Na99mTcO4from entering brain cells [6,7].

The biodistribution and kinetics of radiochemicals can be altered by a variety of chemical agents, as is widely known [8,9]. Without knowing that these chemical agents are being used, the images can be affected to give poor organ visualization, possibly necessitating repeating the procedure, and resulting in unnecessary irradiation or even misdiagnosis [10]. The effect of CS on the biodistribution of radiochemicals has not been fully evaluated. The clearance of 99mTc-pentetic acid aerosols is markedly increased in both sarcoidosis and other inflammatory lung diseases. However, the limitations of 99mTc-pentetic acids include the fact that cigarette smoking will also cause increased clearance [11]. Moreover, the pulmonary uptake of 99mTc-HMPAO (hexamethylprophylenoaminooxin) induced by smoking appears to be partially reversible after the cessation of smoking [12]. We evaluated the biodistribution as an experimental model to understand the action of various chemical agents [13-16]. This study deqals with possible changes in Na99mTcO4 biodistribution induced by the effects of CS in an animal model.

Methods

Adult male BALB/c mice were housed, 5 per cage, in a controlled environment room, with light/dark cycle conditions (12 h light/12 h dark, lights on at 6 p.m.), for an acclimatization period of >3 weeks at an ambient temperature was kept at 25 ± 2°C. The animals had free access to water and food.

Male BALB/c mice (n = 15), weighting 20–22 g, were exposed to smoke-air mixture of commercial filtered Virginia cigarettes, 3 times/day for 1 (CS1d), 5 (CS5d) or 10 (CS10d) days by whole body exposure in an inhalation chamber. A control group (n = 5), sham-smoke (exposed to environment air), was also used. This protocol was performed twice with a total of 40 animals, which were weighed at the end of the experiment.

Each group of mice was placed in the inhalation chamber (40 cm long, 30 cm wide and 25 cm high), inside an exhaustion chapel. A cigarette was coupled to a plastic 60 ml syringe so that puffs could be drawn in and subsequently expelled into the exposure chamber. We aspirated one litre of smoke from one cigarette with this syringe (20 puffs of 50 ml) and immediately injected the puff into the chamber. The 5 animals of each group were maintained in this smoke-air condition for 6 min (~ 3 %), and the inhalation chamber was opened, by removing its cover, and the smoke evacuated for 1 min by exhaustion of the chapel. This cigarette exposition was repeated three times (3 × 6 min) with intervals of 1 min (exhaustion). We repeated this procedure 3 times per day (morning, lunch time and afternoon) resulting in a 54 min of CS exposition of 9 cigarettes. This protocol has been described by us elsewhere [17] and was an experimental protocol approved by the Instituto de Biologia Roberto Alcantara Gomes Animal Research Ethics Committee – UERJ.

Twenty-four hours after exposure, the mice received 0.3 ml of Na99mTcO4 (7.4 MBq) via the ocular plexus, and 30 min later, they were rapidly killed. Heart perfusion was performed with saline at constant pressure of 25 cm H2O to clear organs of blood for 5 min. The organs were isolated (bones, brain, heart, intestine, kidney, liver, lungs, muscle, pancreas, spleen, stomach, testis and thyroid), their weights determined, and the organs and blood sample radioactivity of Na99mTcO4 measured by a gamma-counter NaI (TI) (Cobra Auto-gamma, Packard Instrument Co.; Downers Grove, Illinois, USA). The percentage per gram of tissue of injected dose (%ID/g) was determined for each organ. Statistical analyses involved one-way ANOVA, followed by the Tukey-Kramer Multiple Comparisons Test, with the significance level being p < 0.05. InStat Graphpad software was used to perform statistical analysis (GraphPad InStat version 3.00 for Windows 95, GraphPad Software, San Diego Ca, USA).

Results

The effects of CS on the biodistribution of Na99mTcO4 in isolated organs can first be seen in Table 1, which shows that CS decreased the %ID/g in red blood cells, bone, kidney, lung, spleen, stomach, testis and thyroid of the exposed mice. The greatest decrease was at CS10d in kidney (p < 0.001), spleen and testis (p < 0.01). In the stomach, CS exposure changes the %ID/g for CS1d, CS5d and CS10d (p < 0.05) were comparable with the controls. Table 2 shows that CS did not change the %ID/g of Na99mTcO4 significantly in brain, heart, intestine, liver, muscle and pancreas of exposed animals.

Table 1. Organs in which CS significantly changed (%ID/g) Na99mTcO4 biodistribution (mean ± SD).

Table 2. Organs in which CS unchanged (%ID/g) Na99mTcO4 biodistribution (mean ± SD).

Discussion

Cigarette smoke is a complex mixture of chemicals containing more than 4000 different constituents. Some of the compounds identified include pyridine alkaloids, such as nicotine, as well as ammonia, acrolein, phenols, acetaldehyde, N-nitrosamine; aromatic hydrocarbons (such as benzopyrene), combustion gases (e.g. carbon monoxide, nitrogen oxides, and hydrogen cyanide), trace metals, α-emitter radioactive elements such as polonium, radium, and thorium. Most of these compounds are produced by pyrolysis and distillation in the zone immediately behind the lighted tip of a cigarette, where the temperature reaches 950°C [18,19]. It has been estimated that undiluted mainstream smoke contains as much as 30 mg of tar and 5 mg of nicotine in an unfiltered regular tar cigarette or 0.5 mg tar and 0.05 mg nicotine in a filtered low-tar cigarette [20].

Radionuclides have been used to investigate diseases related to smoking [21,22]. In a recent study, Iwado et al. [23] demonstrated a decrease in the vasomotor response by PET (positron emission tomography) in the endothelium, in smokers. Moreover, acute CS can diminish cerebral blood flow, as was shown with technetium-99m-labelled ethylcysteine in single-photon emission tomography (SPET) on 10 healthy human volunteers [24]. However, there were no changes in biodistribution in the brain in our study. However, the blood-brain barrier prevents Na99mTcO4 from entering normal brain, and the radioactivity detected may represent a minimal amount of Na99mTcO4 from blood in brain circulation not cleared with our perfusion protocol.

Our experimental model showed that CS could affect %ID/g of Na99mTcO4 distribution in certain organs but not others. These changes vary according to the time of exposure; CS10d organs had lower %ID/g when compared to CS5d and CS1d, except for red blood cells, where there was lower %ID/g in CS5d. In this study, CS affected Na99mTcO4 %ID/g in red blood cells, bone, kidney, lung, spleen, stomach, testis and thyroid. It is noteworthy that some of these organs have also been associated with CS-induced cancer in humans [25].

Cigarette smoke can interfere with the ability of bone cells to participate in repairing and remodelling events [26]. This could be one of the mechanisms leading to the development of osteoporosis. Pathological analysis of the kidney by Cigremes et al. [27] has shown severe degeneration of this tissue with advanced hydrophobic degeneration of kidney tubules in the CS exposed animals.

Kidney radioactivity decreased with CS exposure as a function of time. There are two different effects of CS; first, less availability of Na99mTcO4 due to diminished blood flow to the kidney; and the second is increased permeability or secretion of Na99mTcO4. Further studies to determine the levels of Na99mTcO4 in the urine following CS exposure may conclude whether the decrease in radioactivity is as a result of one of these above changes.

Significant dependence of alveolar deposition on flow rate, but not lung function, was found in young non-symptomatic cigarette smokers and in older non-smokers with 99mTc-polystyrene particles [28]. This could explain the significant decrease of Na99mTcO4 %ID/g in mouse lung at CS10d. Lungs are the main target of cigarette smoke [17], and a change in biodistribution of Na99mTcO4 in this experimental design was anticipated. Sopori et al. [29] have reported results on spleen cells from animals subjected to heavy doses of cigarette smoke which show a significant reduction in the natural killer cell-mediated proteolysis activity and a decreased response to concanavalin A.

There is a higher incidence of gastric cancer in smokers than non-smokers and cigarette smoking has also a strong association with colon cancer [30]. The uptake of Na99mTcO4 was significantly reduced in the stomach in our study, although not in the intestine. Technetium99m is secreted via the stomach mucous and transferred into the intestine, which leads to an anticipated reduction of its radioactivity in intestine. Non-significant reduction of 99mTc activity in the intestine is probably due to a great variability in radioactivity measured in this organ among animals.

Rajpurkar et al. [31] analysed chronic cigarette smoke on rat testis, and observed apoptosis, which may be one of the pathogenic mechanisms responsible for defective spermatogenesis in these animals, Fisher et al. [32] showed that chronic smokers have higher thyroxin levels and a lower thyroid-stimulating hormone level than non-smokers or former smokers. These results corroborate the effects on specific organs by CS, which validates this experimental design as a method to seek alterations of Na99mTcO4 biodistribution in mice.

The knowledge of radionuclide biodistribution due to chemical agents will help physicians avoid misinterpreting images and, thus from making incorrect diagnoses. Such information also helps to prevent or treat possible adverse reactions to radionuclides [15]. Therefore, developing models to study the interactions of chemical agents and radiopharmaceuticals will be of considerable help in understanding this problem. CS has many compounds and smoking habits vary in the population; a direct association between the CS effects and the biodistribution of 99mTc has not previously been reported. However, we cannot comment on how CS changes the biodistribution in other radionuclides, radiochemicals and radiopharmaceuticals. The use of laboratory animals under controlled experimental conditions provides a good model to test the hypothesis that CS can change their biodistribution.

When comparing the sensitivity of CS in BALB/c mice to Na99mTcO4 biodistribution, we cannot exclude the possibility that C57BL6 mice will give better results in the future. When Na99mTcO4 is used as a powerful diagnostic tool in nuclear medicine for examining patients to assess the brain and thyroid, CS can cause alterations in the readings.

Conclusion

CS induced changes of Na99mTcO4 biodistribution in exposed BALB/c mice. Na99mTcO4 distribution on kidney, lung, spleen, testis and thyroid decreased progressively with CS time exposure from 1 to 10 days. The Na99mTcO4 distribution in stomach and red blood cells was affected from the first day of CS exposure.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

SSV – carried out the experimental procedure with the mouse exposed to CS, performed the statistical analysis and write the manuscript.

EACL – carried out the experimental procedure with Na99mTcO4 (7.4 MBq) via the ocular plexus.

GFD – determined the radioactivity of the Na99mTcO4 in a counter NaI (TI)

MB-F – conceived of the study and participated in its design and coordination.

LCP – conceived of the study and participated in its design and coordination.

All authors read and approved the final manuscript.

Acknowledgements

This research was supported by Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

References

  1. Rahman I, MacNee W: Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease.

    Thorax 1996, 51:348-350. PubMed Abstract OpenURL

  2. Peto R, Lopez AD, Boreham J, Thun M, Heath CJr: Mortality from tobacco in developed countries: indirect estimation from national vital statistics.

    Lancet 1992, 339:1268-1278. PubMed Abstract | Publisher Full Text OpenURL

  3. World Health Organization Mortality Statistics, World Health Statistics Annual 1997–1999 [http://http. //www.who.int/whosis/mort] webcite

  4. Hom RK, Katzenellenbogen JA: Technetium-99m labeled Receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results.

    Nucl Med Biol 1997, 24:485-498. PubMed Abstract | Publisher Full Text OpenURL

  5. Hladik J, Snozzi M, Bachofen R: Incorporation of reaction centers into submitochondrial particles resulting in light induced electron transfer.

    Biochem Biophys Res Commun 1987, 14:170-177. Publisher Full Text OpenURL

  6. Early PJ, Sodee DB: Principles and practice of nuclear medicine. MosebyYear Book: London; 1995. OpenURL

  7. Saha GB, Go RT, MacIntyre WJ: Radiopharmaceucticals for cardiovascular imaging.

    Int J Rad Appl Instrum B 1992, 19:1-20. PubMed Abstract OpenURL

  8. Hesslewood S, Leung E: Drug interactions with radiopharmaceuticals.

    Eur J Nucl Med 1994, 21:348-356. PubMed Abstract | Publisher Full Text OpenURL

  9. Sampson CB: Adverse reactions and drug interactions with radiopharmaceuticals.

    Drug Safety 1993, 8:280-294. PubMed Abstract OpenURL

  10. Lentle BC, Scott JR: Iatrogenic alterations in radionuclide biodistribution.

    Semin Nucl Med 1979, 9:131-143. PubMed Abstract OpenURL

  11. Baughman RP, Fernandez M: Radionuclide imaging in interstitial lung disease.

    Curr Opin Pulm Med 1996, 2:376-379. PubMed Abstract OpenURL

  12. Shih WJ, Lee JK, Coupal J, Lai YL, Grunwald F, Biersack H: Diminished Tc-99m HMPAO pulmonary uptake in ex-smokers.

    Clin Nucl Med 1995, 20:788-791. PubMed Abstract OpenURL

  13. Capriles PVSZ, Dias APM, Costa TEMM, Oliveira MBN, Faria MVC, Moura EG, Abreu BAL, Bernardo-Filho M: Effect of eggplant (solanum melongena) extract on the in vitro labeling of blood elements with technetium-99m and on the biodistribution of sodium pertechnetate in rats.

    Cell Mol Biol (Noisy-le-grand) 2002, 48:771-776. PubMed Abstract OpenURL

  14. Feliciano GD, Lima EAC, Pereira MJDS, Oliveira MBS, Moreno SRF, Mattos DMM, Jales RL, Bernardo-Filho M: Effect of a chayotte (sechium edule) extract on the labeling of red blood cells and plasma proteins with technetium-99m: in vitro and in vivo studies.

    Cell Mol Biol (Noisy-le-grand) 2002, 48:751-755. PubMed Abstract OpenURL

  15. Gomes ML, Braga ACS, Mattos DMM, Freitas RS, Boasquevisque E, Bernardo-Filho M: The effect of mitomycin-C on the biodistribution of 99Tcm-MDP in Balb/c mice.

    Nucl Med Commun 1998, 19:1177-1179. PubMed Abstract OpenURL

  16. Gomes ML, Mattos DM, Freitas RS, Dire GF, Lima EA, Souza SM, Bernardo-Filho M: Evaluation of the effect of mitomycin-C on the bioavailability of technetium-99m-labelled sodium pyrophosphate in mice.

    Cell Mol Biol (Noisy-le-grand) 2002, 48:757-759. PubMed Abstract OpenURL

  17. Valenca SS, da Hora K, Castro P, Moraes VG, Carvalho L, Porto LC: Emphysema and metalloelastase expression in mouse lung induced by cigarette smoke.

    Toxicol Pathol 2004, 32:351-356. PubMed Abstract | Publisher Full Text OpenURL

  18. Rodgman A, Smith CJ, Perfetti TA: The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components.

    Hum Exp Toxicol 2000, 19:573-595. PubMed Abstract | Publisher Full Text OpenURL

  19. Skwarzec B, Ulatowski J, Struminska DI, Borylo A: Inhalation of 210Po and 210Pb from cigarette smoking in Poland.

    J Environ Radioact 2001, 57:221-230. PubMed Abstract | Publisher Full Text OpenURL

  20. Hoffmann D, Hoffmann I: The changing cigarette, 1950–1995.

    J Toxicol Environ Health 1997, 50:307-364. PubMed Abstract | Publisher Full Text OpenURL

  21. Meeder JG, Blanksma PK, van der Wall EE, Anthonio RL, Willemsen AT, Pruim J, Vaalburg W, Lie KI: Long-term cigarette smoking is associated with increased myocardial perfusion heterogeneity assessed by positron emission tomography.

    Eur J Nucl Med 1996, 23:1442-1447. PubMed Abstract | Publisher Full Text OpenURL

  22. Shih WJ, Gruenwald F, Biersack HJ, Berger R, Brandenburg S, Coupal J, Ryo UY: Tc-99m HMPAO diffuse pulmonary uptake demonstrated in cigarette smokers.

    Clin Nucl Med 1991, 16:668-672. PubMed Abstract OpenURL

  23. Iwado Y, Yoshinaga K, Furuyama H, Ito Y, Noriyasu K, Katoh C, Kuge Y, Tsukamoto E, Tamaki N: Decreased endothelium-dependent coronary vasomotion in healthy young smokers.

    Eur J Nucl Med Mol Imaging 2002, 29:984-990. PubMed Abstract | Publisher Full Text OpenURL

  24. Yamamoto Y, Nishiyama Y, Monden T, Satoh K, Ohkawa M: A study of the acute effect of smoking on cerebral blood flow using (99m)Tc-ECD SPET.

    Eur J Nucl Med Mol Imaging 2003, 30:612-614. PubMed Abstract | Publisher Full Text OpenURL

  25. De Flora S, D'Agostini F, Balansky R, Camoirano A, Bennicelli C, Bagnasco M, Cartiglia C, Tampa E, Longobardi MG, Lubet RA, Izzotti A: Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis.

    Mutat Res 2003, 523–524:237-252. OpenURL

  26. Liu X, Kohyama T, Kobayashi T, Abe S, Kim HJ, Reed EC, Rennard SI: Cigarette smoke extract inhibits chemotaxis and collagen gel contraction mediated by human bone marrow osteoprogenitor cells and osteoblast-like cells.

    Osteoporos Int 2003, 14:235-242. PubMed Abstract | Publisher Full Text OpenURL

  27. Cigremis Y, Turkoz Y, Akgoz M, Sozmen M: The effects of chronic exposure to ethanol and cigarette smoke on the level of reduced glutathione and malondialdehyde in rat kidney.

    Urol Res 2004, 32:213-218. PubMed Abstract | Publisher Full Text OpenURL

  28. Agnew JE, Pavia D, Clarke SW: Factors affecting the alveolar deposition of 5 microns inhaled particles in healthy subjects.

    Clin Phys Physiol Meas 1985, 6:27-36. PubMed Abstract | Publisher Full Text OpenURL

  29. Sopori ML, Gairola CC, DeLucia AJ, Bryant LR, Cherian S: Immune responsiveness of monkeys exposed chronically to cigarette smoke.

    Clin Immunol Immunopathol 1985, 36:338-344. PubMed Abstract | Publisher Full Text OpenURL

  30. Shin VY, Wang HY, Liu ES, Koo MW, Cho CH: Differential effects of cigarette smoke extracts on cell proliferation in gastric and colon cells.

    Cancer Invest 2003, 21:200-207. PubMed Abstract | Publisher Full Text OpenURL

  31. Rajpurkar A, Jiang Y, Dhabuwala CB, Dunbar JC, Li H: Cigarette smoking induces apoptosis in rat testis.

    J Environ Pathol Toxicol Oncol 2002, 21:243-248. PubMed Abstract OpenURL

  32. Fisher CL, Mannino DM, Herman WH, Frumkin H: Cigarette smoking and thyroid hormone levels in males.

    Int J Epidemiol 1997, 26:972-927. PubMed Abstract | Publisher Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2385/5/1/prepub